ContextVision - Mandatory notification of trade - primary insider
ContextVision AB (CONTX) · publisert 26. oktober 2022 kl. 13:28 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Markus Hökerberg | CFO | acquisition | 11 600 | 8,71 NOK | 26. oktober 2022 | SE0014731154 | CONTX | llm |
Meldingstekst
STOCKHOLM - October 26 2022 - Markus Hökerberg, CFO of ContextVision, has during
October 20-26, 2022 purchased 11,600 shares in ContextVision AB at an average
price of NOK 8.71 per share. After the transaction, Mr Hökerberg holds a total
of 28,162 shares in ContextVision AB.
With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"),
kindly note the following primary insider share transaction:
Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Markus Hökerberg
Relation to listed entity: CFO
Trade: 11,600 shares
Date: 26.10.2022
Average purchase price: NOK 8,71 per share
Primary insider's total shareholdings post-purchase: 28,162 shares
Primary insider's percentage shareholding post-purchase: 0.04%
###
For further information, please contact ContextVision's CEO, Gerald Pötzsch, at
+46 8 750 35 50 or gerald.potzsch@contextvision.com or
visit www.contextvision.com (https://www.globenewswire.com/Tracker?data=3MaQGqfSt
sB_Z2n6YL96mk
-0dfygLw6oN4eKvMWXKupICwsDDzA5ube1toUXebPYzar4qnu3TeaXF33IVlLZ60EyMCEFEOWZap0EhVS
qE-zUKei2pFNr5cBFltRYMNo6kn7oL7CJxcgVx-hYON67FOGIkP2rl4
-54NJMeD5MzrIVSQFWmgmZB085ANCWw_
-3WhU_QFycYwSw79n9hRO8bD7Hmgptb56Phn4abKPm1hKO_3dkThorqVpb9FHkE5KXb2U2zArc9gueaSX
iPxhqyw==).
###
About ContextVision
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X
-ray and MRI equipment around the world.
Our expertise is to develop powerful software products, based on proprietary
technology and artificial intelligence for image-based applications. Our cutting
-edge technology helps clinicians accurately interpret medical images, a crucial
foundation for better diagnosis and treatment.
The company, established in 1983, is based in Sweden with local representation
in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock
Exchange under the ticker CONTX.